Literature DB >> 6818603

Influence of age on mianserin pharmacokinetics.

A C Altamura, T Melorio, G Invernizzi, R Gomeni.   

Abstract

The pharmacokinetics of Mianserin (MIA) after acute administration have been studied in nine volunteers, divided into two groups according to age. The subjects were given a single oral dose of 30 mg MIA. The plasma peak time was shorter in the younger subjects than in the older. In general, the concentrations of MIA in the plasma were higher in the older subjects than in the younger, and in the former group there was no relationship between administered dose (mg/kg) and plasma levels. The area under curve, volume of distribution and clearance were significantly different in the two groups. The side effects (both incidence and type) differed in the two groups. There were no significant changes in blood pressure, either supine or standing. The sedative effect was more marked in the young than in the elderly subjects. A relationship between drowsiness and MIA plasma levels was observed only in the younger subjects.

Mesh:

Substances:

Year:  1982        PMID: 6818603     DOI: 10.1007/bf00433747

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN.

Authors:  A D BENDER
Journal:  J Am Geriatr Soc       Date:  1965-03       Impact factor: 5.562

2.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

3.  Influence of first-pass effect on availability of drugs on oral administration.

Authors:  M Gibaldi; R N Boyes; S Feldman
Journal:  J Pharm Sci       Date:  1971-09       Impact factor: 3.534

4.  Long-term treatment with mianserin: a clinical study with plasma levels.

Authors:  A C Altamura; S R Bareggi; C M Cornaggia; G Grieco; G Invernizzi; T Melorio; L Zecca
Journal:  Adv Biochem Psychopharmacol       Date:  1982

5.  Contribution to the pharmacokinetics of amitriptyline.

Authors:  V E Ziegler; J T Biggs; A B Ardekani; S H Rosen
Journal:  J Clin Pharmacol       Date:  1978-10       Impact factor: 3.126

6.  Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years.

Authors:  L P Novak
Journal:  J Gerontol       Date:  1972-10

7.  Mass fragmentographic assay of nanogram amounts of the antidepressant drug mianserin hydrochloride (Org GB 94) in human plasma.

Authors:  J J de Ridder; P C Koppens; H J van Hal
Journal:  J Chromatogr       Date:  1977-05-01

Review 8.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

Review 9.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Pharmacokinetics of amitriptyline in the elderly.

Authors:  J F Henry; C Altamura; R Gomeni; M P Hervy; F Forette; P L Morselli
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-01
View more
  7 in total

1.  Variability in the elimination of mianserin in elderly patients.

Authors:  E J Begg; J R Sharman; J E Kidd; R Sainsbury; D W Clark
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

2.  Mianserin metabolites.

Authors:  A C Altamura; T Melorio
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

3.  Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants.

Authors:  A C Altamura; M Mauri
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of fluoxetine.

Authors:  A C Altamura; A R Moro; M Percudani
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

5.  Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.

Authors:  A C Altamura; T Melorio; G Invernizzi; F Colacurcio; R Gomeni
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin.

Authors:  A C Altamura; M C Mauri; F Colacurcio; P L Scapicchio; C Hadjchristos; G Carucci; M Minervini; R Montanini; M Perini; N Rudas
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

Authors:  R J Riley; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.